TBIO telesisbio.com: Operating Profitability

Telesis Bio Inc. (TBIO) - corporate logo

Telesis Bio, Inc. (TBIO) is making a breakthrough in synthetic biology by offering the BioXp system for rapid gene synthesis. The operating profit margin confirms this potential, and this metric equals -200.80. Growth relies on the automation of R&D processes within the pharmaceutical sector, although risks are linked to the need to scale B2B trust in the accuracy of robotic solutions within a professional environment.

TBIO: Telesis Bio Inc. Operating Sales Margin 04/28/2023 - 10/05/2024

Financial and market metric breakdowns for Telesis Bio, Inc. (TBIO)

- share price and consensus valuation forecast:
- company stock capitalization data:
Summary company analysis:Telesis Bio, Inc, TBIO
Brand item of Telesis Bio, Inc

The resilience of Telesis Bio, Inc. (TBIO) is determined by its ability to monetize its leadership in DNA and mRNA synthesis automation amid large-scale R&D expenditures. By analyzing the operating profit spread, an investor can identify the portion of revenue remaining after all production costs are paid, but before accounting for financial obligations and taxes, which allows for an objective assessment of the business model's internal efficiency and the determination of the company's fair market discount.

Competitor analysis

Operating Sales Margin TEM|QGEN - Operating Profitability Margin|Operating Margin IONS|RGEN - Operating Return on Sales|Operating Profitability Avidity RNA|Operating Margin CRISPR Therapeutics Corp CRSP|GeneDx Corp - Operating Margin|Ultragenyx Pharma (RARE) - Operating Sales Margin|beamtx.com (BEAM) - Operating Profitability|SRPT: Operating Profit Ratio|Operating Sales Margin TWST|TXG - Operating Profitability Margin|Operating Margin NTLA|Profitability of Operations Stoke Therapeutics|Operating Profitability BioLife Solutions BLFS|Wave Life Sciences (WVE) - Operating Return on Sales|Maze Therapeutics, Inc. - Operating Margin|Profitability of Operations Sionna Therapeutics, Inc. SION|Prime Medicine Bio (PRME) - Operating Profitability|TSHA: Operating Profit Ratio|Operating Profitability uniQure Pharma|MGTX - Operating Profitability Margin|Operating Margin RGNX|Operating Profitability SLDB (Solid Biosciences)|Ocugen Corp - Operating Sales Margin|PACB: Return on Sales by Operating Profit|benitec.com - Operating Margin|DSGN - Operating Margin|RCKT: Operating Margin|FDMT (4D Molecular Therapeutics Inc) - Operating Profitability|Operating Sales Margin LXEO|Operating Profitability KRRO|Operating Margin EDIT|SLN - Operating Return on Sales|Operating Margin PRQR (ProQR)|CDXS - Operating Sales Margin|Sangamo Therapeutics Inc. - Operating Margin|NAUT - Operating Margin|MGX: Operating Margin|Operating Sales Margin Precision BioSciences, Inc.|GBIO (Generation Bio) - Operating Margin|Boundless Bio Inc. (BOLD) - Profitability of Operations|Operating Sales Margin XCUR (exicuretx.com)|Imunon Inc - Return on Sales by Operating Profit|Operating Margin PHIO (Phio Pharmaceuticals Corp)|Operating Profit Rate MBIO|RNAZ - Operating Profitability|Operating Profit Rate BNGO (bionanogenomics.com)|Applied DNA Sciences (APDN) - Operating Profitability|Bluebird Bio - Operating Profit Rate|IPA (ImmunoPrecise Antibodies Ltd) - Operating Margin|Operating Return on Sales Omega Therapeutics, Inc. OMGA|Operating Margin OMIC|RGLS (Regulus Therapeutics Inc.) - Operating Profit Rate|Operating Margin SYRS (Syros Pharmaceuticals Inc.)|Operating Profit Rate TCON|UBX - Operating Profitability